Your browser doesn't support javascript.
Intermediates in SARS-CoV-2 spike-mediated cell entry.
Marcink, Tara C; Kicmal, Thomas; Armbruster, Emily; Zhang, Zhening; Zipursky, Gillian; Golub, Kate L; Idris, Mohab; Khao, Jonathan; Drew-Bear, Jennifer; McGill, Gael; Gallagher, Tom; Porotto, Matteo; des Georges, Amédée; Moscona, Anne.
  • Marcink TC; Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
  • Kicmal T; Center for Host-Pathogen Interaction, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
  • Armbruster E; Department of Microbiology and Immunology, Loyola University Chicago, Maywood, IL, USA.
  • Zhang Z; Structural Biology Initiative, CUNY Advanced Science Research Center, City University of New York, New York, NY, USA.
  • Zipursky G; Department of Biochemistry and Molecular Biophysics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
  • Golub KL; Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
  • Idris M; Center for Host-Pathogen Interaction, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
  • Khao J; Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
  • Drew-Bear J; Center for Host-Pathogen Interaction, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
  • McGill G; Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
  • Gallagher T; Center for Host-Pathogen Interaction, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
  • Porotto M; Digizyme Inc., Brookline, MA, USA.
  • des Georges A; Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
  • Moscona A; Center for Host-Pathogen Interaction, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
Sci Adv ; 8(33): eabo3153, 2022 08 19.
Article in English | MEDLINE | ID: covidwho-2001755
ABSTRACT
SARS-CoV-2 cell entry is completed after viral spike (S) protein-mediated membrane fusion between viral and host cell membranes. Stable prefusion and postfusion S structures have been resolved by cryo-electron microscopy and cryo-electron tomography, but the refolding intermediates on the fusion pathway are transient and have not been examined. We used an antiviral lipopeptide entry inhibitor to arrest S protein refolding and thereby capture intermediates as S proteins interact with hACE2 and fusion-activating proteases on cell-derived target membranes. Cryo-electron tomography imaged both extended and partially folded intermediate states of S2, as well as a novel late-stage conformation on the pathway to membrane fusion. The intermediates now identified in this dynamic S protein-directed fusion provide mechanistic insights that may guide the design of CoV entry inhibitors.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Spike Glycoprotein, Coronavirus / SARS-CoV-2 / COVID-19 Limits: Humans Language: English Journal: Sci Adv Year: 2022 Document Type: Article Affiliation country: Sciadv.abo3153

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Spike Glycoprotein, Coronavirus / SARS-CoV-2 / COVID-19 Limits: Humans Language: English Journal: Sci Adv Year: 2022 Document Type: Article Affiliation country: Sciadv.abo3153